Product Reports Resources Pricing Login Book a demo
Investor profile

OrbiMed

Direct investor

Private Equity · Founded 1989 · New York City, United States

Leading investment fund focused on health care companies

Sven H. Borho, CFAManaging Partner
Carl L. Gordon, Ph.D., CFAManaging Partner
W. Carter Neild, CFAManaging Partner
Geoffrey C. Hsu, CFAGeneral Partner
C. Scotland StevensGeneral Partner
David Bonita, M.D.General Partner
Matthew RizzoGeneral Partner
Peter Thompson, M.D.General Partner
01 · Biggest holdings

OrbiMed’s biggest holdings

Dealroom has OrbiMed’s ownership percentage in only 1 company, too few to size its stakes.

Request ownership data
02 · Exits

OrbiMed’s biggest exits

Portfolio companies that IPO’d or were acquired at $1B+, with the valuation recorded at exit and — for those still public — their value today. Exit events come from each company’s funding-round history; entry stage from OrbiMed’s transaction record.

IPO · 2014
Entered Series B+Now $50BHealth
$1.8B IPO · 2015
Entered Series B+Now $46BHealth
$1.6B IPO · 2018
Entered Series B+Now $22BHealth
$373M IPO · 2015
Entered Series B+Now $17BHealth
$12B acquisition · 2022
Now $2.2BHealth
$385M IPO · 2013
Entered Series B+Now $12BHealth
$11B acquisition · 2013
Entered Series B+Health
$415M IPO · 2015
Entered Series B+Now $10BHealth
IPO · 2007
Entered Series B+Now $10BHealth
$163M IPO · 2017
Entered Series ANow $10BHealth
$809M IPO · 2023
Entered Series B+Now $9.2BHealth
$391M IPO · 2018
Entered Series B+Now $7.8BHealth
03 · Portfolio market map

OrbiMed’s portfolio companies

The 60 highest-funded portfolio companies, of 393 tracked.

PharmEasy
Health
$710M
Caris Life Sciences
Health · Unicorn
$6.1B
Treeline Biosciences
Health · Unicorn
$2.1B
Miaoshou Doctor
Health · Unicorn
$2.3B
Zai Lab
Health · Unicorn
$2.1B
Beijing Yuanxin Technology
Unicorn
$2.3B
I-Mab Biopharma
Health
$186M
Odyssey Therapeutics
Health
$724M
XtalPi
Health · Unicorn
$2.8B
Avenzo Therapeutics
Health
$240M
Mirador Therapeutics
Health · Unicorn
$2.0B
AbCellera Biologics
Health · Unicorn
$1.7B
Century Therapeutics
Health
$272M
ACELYRIN
Health
Guardant Health
Health · Decacorn
$22B
InSilico Medicine
Health · Unicorn
$3.1B
Dingdang Kuaiyao
Health
$880M
Olema Oncology
Health
$550M
Invivyd
Health · Unicorn
$1.8B
Arvinas
Health
$12M
Crinetics Pharmaceuticals
Health · Unicorn
$7.8B
SpringWorks Therapeutics
Health · Unicorn
$3.3B
Galecto | Damora Therapeutics
Health · Unicorn
$1.9B
Scorpion Therapeutics
Health · Unicorn
$2.5B
RayzeBio
Health · Unicorn
$3.7B
Constellation Pharmaceuticals
Health · Unicorn
$1.7B
Verdiva Bio
Health · Unicorn
$2.0B
Adaptive Biotechnologies
Health · Unicorn
$4.0B
Upstream Bio
Health
$100M
Arrail Dental Clinic
Health
$800M
Cullinan Therapeutics
Health
$808M
Acerta Pharma
Health · Unicorn
$7.0B
Candid Therapeutics
Health · Unicorn
$2.0B
Angitia Biopharmaceuticals
Health
$520M
Alentis Therapeutics
Health
$900M
Windward Bio
Health
$825M
Terremoto Biosciences
Health
$875M
Tyra Biosciences
Health · Unicorn
$1.2B
Pionyr Immunotherapeutics
Health · Unicorn
$1.1B
ReCode Therapeutics
Health
$600M
Aspen Neuroscience
Health
$738M
Erasca
Health · Unicorn
$6.2B
Shattuck Labs
Health
$607M
Capstan Therapeutics
Health · Unicorn
$2.1B
Clover Biopharmaceuticals
Health
$337M
Delfi Diagnostics
Health
$900M
Adarx Pharmaceuticals
Health
$800M
Ikena Oncology
Health
$629M
ADCendo
Health
$712M
Harmony Biosciences
Health · Unicorn
$1.7B
Relypsa
Health
$10M
Sonendo
Health
$11M
Star Therapeutics
Health
$500M
ArriVent Biopharma
Health · Unicorn
$1.1B
Gelesis
Health
$54M
Harbour BioMed
Health · Unicorn
$1.1B
Harpoon Therapeutics
Health
$475M
Nautilus
Health
$59M
Iambic Therapeutics
Health
$400M
Amolyt Pharma
Health
$800M
04 · Portfolio founders

Where OrbiMed’s portfolio founders come from

139 founders across the 100 highest-funded portfolio companies — by current location, university attended, and the companies they worked at before founding. Sourced from the founder records the API links to each portfolio company.

LocationCount
  1. United States93
  2. China12
  3. Denmark6
  4. Canada4
  5. Israel4
  6. Australia3
  7. India3
  8. Netherlands3
  9. United Kingdom3
  10. Germany2
UniversityCount
  1. Harvard University11
  2. Massachusetts Institute of Technology8
  3. Stanford University5
  4. University of California, Berkeley4
  5. Wharton School of the University of Pennsylvania4
  6. Columbia University3
  7. Harvard Medical School3
  8. University of Copenhagen3
  9. University of Texas at Austin3
  10. University of Virginia3
Previous companyCount
  1. Novartis6
  2. Alantos Pharmaceuticals5
  3. Genentech5
  4. Massachusetts Institute of Technology5
  5. McKinsey & Company5
  6. Sanofi Aventis5
  7. Harvard Medical School3
  8. Lucentis3
  9. MIT-IBM Watson AI Lab3
  10. Aiolos Bio2
Ecosystem map

OrbiMed in the New York City ecosystem

The OrbiMed office with the hot startups, most funded companies and other investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →